Cellectis S.A.
CLLS
$3.24
-$0.08-2.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.71% | -11.07% | -83.87% | 58.15% | 25.23% |
| Total Depreciation and Amortization | -9.65% | -5.20% | -1.33% | 4.70% | 4.57% |
| Total Amortization of Deferred Charges | 61.87% | 61.87% | 61.87% | 998.55% | 998.55% |
| Total Other Non-Cash Items | -22.37% | 118.83% | 461.33% | -0.74% | 6,256.82% |
| Change in Net Operating Assets | 25.23% | -157.98% | -177.50% | -132.54% | -119.61% |
| Cash from Operations | -24.83% | -229.19% | -271.39% | -146.35% | -164.76% |
| Capital Expenditure | -7.45% | 19.20% | 8.63% | -5.28% | -9.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 182.69% | 59.86% | 72.94% | 32.13% | 66.17% |
| Cash from Investing | 173.69% | 58.70% | 71.32% | 31.27% | 65.02% |
| Total Debt Issued | -- | -- | -- | -61.12% | -70.07% |
| Total Debt Repaid | -3.24% | -7.69% | -0.81% | 2.98% | 2.98% |
| Issuance of Common Stock | -- | -99.91% | -99.95% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | 99.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 44.83% | 28.50% | 27.74% | 74.20% | 30.72% |
| Cash from Financing | -71.45% | -124.03% | -118.81% | -107.59% | -107.22% |
| Foreign Exchange rate Adjustments | 170.39% | 314.26% | 242.73% | -47.18% | -277.01% |
| Miscellaneous Cash Flow Adjustments | -- | -100.00% | -100.00% | 250.00% | 100.00% |
| Net Change in Cash | 72.86% | -2,089.17% | -1,348.94% | -216.48% | -238.01% |